NAD+ Benefits: What It Actually Does, and What the Science Really Shows

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. Two jobs make it matter for how you feel: it's central to energy metabolism — the machinery that converts what you eat into ATP, your cells' usable fuel — and it's a required cofactor for repair and signaling enzymes like the sirtuins and PARPs that maintain your DNA and regulate cellular stress responses.

The reason it's become a longevity talking point is simple: NAD+ levels decline with age. As they drop, mitochondrial function and cellular repair capacity decline with them. A review in Plastic and Reconstructive Surgery, written by an author from an NAD+ supplement company, summarizes the preclinical work: raising cellular NAD+ improved mitochondrial function and activated the recycling of damaged mitochondria in laboratory models (Conlon, 2022). That single fact — it powers your cells and it falls with age — is the logic behind nearly every NAD+ benefit below.

Energy is the benefit people seek most. NAD+ is a direct input to how mitochondria produce ATP, so the energy rationale is mechanistic: NAD+ is required for oxidative phosphorylation (Covarrubias et al., 2021). People who try NAD+ for energy often describe steadier stamina, and energy is the most common reason people ask about NAD injections. Those are personal reports, not trial results. No controlled human trial has yet shown that raising NAD+ reduces everyday fatigue in healthy adults.

NAD+ sits at the center of the longevity conversation because it fuels the enzymes that protect your genome. The same review notes NAD+ is essential for DNA-repair enzymes, helps clear senescent ("worn-out") cells and damaged proteins, and points to animal models in which NAD+ restoration reversed markers of vascular aging — the kind of cellular housekeeping that erodes with age (Conlon, 2022).

The honest boundary: NAD+ does not "reverse aging," and no legitimate provider should tell you it does. What the science supports is that NAD+ is part of the biology of aging in animal models. Whether raising it changes human aging has not been tested.

Because neurons are energy-hungry, NAD+ is being studied for cognitive support — mental clarity, focus, and mood are the benefits people describe. Preclinical work summarized in the same regenerative-medicine review has shown neuroprotective effects and improved cognition in animal models of neurodegeneration (Conlon, 2022). That's a promising signal, but it's important to be precise: this is early research, not a treatment for any neurological disease. If you see NAD+ marketed as a therapy for Alzheimer's, Parkinson's, or addiction, that's overreach — the current evidence is mechanistic and preliminary.

A common question is whether NAD+ helps with weight. The realistic answer: NAD+ is part of how cells process energy, and animal research links NAD+ restoration to improved metabolic markers. One human signal: in a 10-week randomized, placebo-controlled trial in postmenopausal women with prediabetes, oral NMN (an NAD+ precursor) increased muscle insulin sensitivity (Yoshino et al., 2021). That is a metabolic marker, not weight loss. NAD+ is not a weight-loss drug, and "does NAD help you lose weight" doesn't have a clean yes. No trial shows NAD+ therapy helps weight loss, and it isn't a substitute for training and nutrition.

"NAD+ for skin" and NAD+ skincare have grown because NAD+ powers the DNA-repair pathways that defend against UV-induced damage, and the same industry-authored review links it to the cell-recycling processes that clear glycation byproducts associated with skin aging (Conlon, 2022). The mechanism is real; the topical and systemic skin-benefit data in humans is still early. Treat skin claims as unproven.

Athletes and high-output people use NAD+ for recovery — the rationale being reduced inflammation and better mitochondrial repair after stress. One human signal worth noting: in a small randomized crossover trial, 12 older men who took nicotinamide riboside (an oral NAD+ precursor) for 21 days showed a higher muscle NAD+ metabolome and lower circulating inflammatory cytokines (Elhassan et al., 2019). That is a blood and muscle biomarker finding with an oral precursor, not injectable NAD+, and not a measured recovery benefit.

Women and men both ask whether NAD+ benefits differ by sex. The biology of NAD+ is the same in both sexes, and the proposed benefits (energy, cellular repair, metabolic and cognitive support) aren't sex-specific. One of the better human NAD+ precursor trials was done in women: oral NMN improved muscle insulin sensitivity in postmenopausal women with prediabetes (Yoshino et al., 2021). Men often come to NAD+ through the energy, recovery and longevity angle, frequently alongside hormone optimization. What differs is the goal someone brings to it.

This is the part most "benefits" articles skip, and it matters more than the benefit list. You'll see NAD+ sold as IV drips, subcutaneous injections, "shots," nasal sprays, and patches — and they are not equivalent.

IV NAD+ enters the bloodstream directly. Subcutaneous injections are absorbed from under the skin. Both avoid gut breakdown, which is why they're the forms used clinically. Injected NAD+ is not simply delivered intact into cells, though: in the one human IV study, infused NAD+ was rapidly cleared from the blood and broken down (Grant et al., 2019). Oral precursors such as nicotinamide riboside raise blood NAD+ in randomized trials (Martens et al., 2018). Patches and nasal sprays have little published human data on how much they deliver. No human trial shows any injected form raises NAD+ inside cells more than oral precursors do, so the route changes convenience and the gut question, not a proven difference in benefit.

You'll also see NMN and NR marketed as "NAD+." They're not — they're precursors your body converts into NAD+. That conversion works, and oral precursors have the most human trial data. Injected NAD+ is not a shortcut around it: much of it is broken down in the blood and rebuilt by cells from the pieces. Neither is "wrong," but they're different tools, and the marketing often blurs the line. We break the comparison down in our NMN vs. NAD+ guide.

A frequent pairing question — people ask about NAD+ and glutathione together because one is framed as cellular energy/repair and the other as your master antioxidant. The rationale is complementary: NAD+ supports mitochondrial energy and repair, glutathione supports the body's antioxidant defense. Whether combining them helps anyone has not been tested, and the specifics belong in a conversation with a prescriber who knows your goals — not a one-size dosing chart.

Here's the part that actually builds trust: the mechanism for NAD+ is excellent, and the human clinical evidence is still maturing. Much of the strongest data is preclinical (cells and animals). Human trials so far, almost all of oral precursors, show promising trends more than definitive outcome proof: a trend toward lower blood pressure and arterial stiffness (Martens et al., 2018), better muscle insulin sensitivity (Yoshino et al., 2021) and lower inflammatory cytokines (Elhassan et al., 2019). Even balanced consumer-health coverage lands here: NAD+ is genuinely interesting, and the claims have outrun the human data (Cleveland Clinic).

What that means for you: NAD+ is a physiologically plausible option worth discussing with a physician, pursued with realistic expectations and medical oversight rather than a subscription box of patches. Anyone promising dramatic, guaranteed results is selling, not informing.

NAD+ is generally well tolerated. With IV NAD+, the most common experience is a temporary infusion "rush" (flushing, mild nausea, chest tightness) if the drip runs too fast; slowing it usually resolves it. With subcutaneous injections there is no drip to slow, and the usual issue is injection-site redness or soreness. See the full breakdown of NAD+ side effects. As with anything, it belongs inside a medical relationship: anyone pregnant or breastfeeding, or managing a significant health condition, should be evaluated first. Read the full picture in our NAD+ guide.

The Protocol MD NAD+ protocol is physician-prescribed and compounded by a licensed 503A pharmacy (compounded NAD+ is not FDA-approved), delivered as a subcutaneous injectable. That means a real evaluation up front, a dose set by a prescriber, and a physician accountable for your protocol. It does not mean injectable NAD+ is proven to work better than oral precursors; that comparison hasn't been tested in humans. See how Protocol MD's physician-prescribed NAD+ works, or start the free Protocol MD assessment.

NAD+ benefits rest on real biology: NAD+ fuels cellular energy, powers DNA repair, and declines with age, which is why people pursue it for energy, healthy aging, cognition, metabolism and recovery. Controlled human trials have not confirmed the benefits people seek, and most human data come from oral precursors measuring blood markers, so the right expectation is "plausible," not "miracle cure." Whatever the route, NAD+ is best started after a physician evaluation, with realistic expectations.